These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7817669)

  • 1. Evidence for a complement-mediated inhibition and an antibody-dependent cellular cytotoxicity of dermal fibroblasts in alopecia areata.
    Abdel-Naser MB; Blume-Peytavi U; Abdel-Fatah A; Orfanos CE
    Acta Derm Venereol; 1994 Sep; 74(5):351-4. PubMed ID: 7817669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from "active" and "normal" areas of alopecia areata.
    Hull SM; Nutbrown M; Pepall L; Thornton MJ; Randall VA; Cunliffe WJ
    J Invest Dermatol; 1991 May; 96(5):673-81. PubMed ID: 1827135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.
    Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
    J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata.
    Norris DA; Duke R; Whang K; Middleton M
    J Invest Dermatol; 1995 May; 104(5 Suppl):8S-9S. PubMed ID: 7738399
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice.
    Li Y; Kilani RT; Pakyari M; Leung G; Nabai L; Ghahary A
    J Cell Physiol; 2018 Mar; 233(3):2590-2601. PubMed ID: 28777458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural abnormalities in the dermal papillae of both lesional and clinically normal follicles from alopecia areata scalps.
    Nutbrown M; MacDonald Hull SP; Baker TG; Cunliffe WJ; Randall VA
    Br J Dermatol; 1996 Aug; 135(2):204-10. PubMed ID: 8881661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.
    Norris DA; Kissinger RM; Naughton GM; Bystryn JC
    J Invest Dermatol; 1988 Jun; 90(6):783-9. PubMed ID: 3373009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo.
    Abdel-Naser MB; Krüger-Krasagakes S; Krasagakis K; Gollnick H; Abdel-Fattah A; Orfanos CE
    Pigment Cell Res; 1994 Feb; 7(1):1-8. PubMed ID: 8072943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence studies on complement components in the hair follicles of normal scalp and of scalp affected by alopecia areata.
    Igarashi R; Morohashi M; Takeuchi S; Sato Y
    Acta Derm Venereol; 1981; 61(2):131-5. PubMed ID: 6165188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to hair follicles in alopecia areata.
    Tobin DJ; Orentreich N; Fenton DA; Bystryn JC
    J Invest Dermatol; 1994 May; 102(5):721-4. PubMed ID: 8176253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell degeneration in alopecia areata. An ultrastructural study.
    Tobin DJ; Fenton DA; Kendall MD
    Am J Dermatopathol; 1991 Jun; 13(3):248-56. PubMed ID: 1867355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different populations of melanocytes are present in hair follicles and epidermis.
    Tobin DJ; Bystryn JC
    Pigment Cell Res; 1996 Dec; 9(6):304-10. PubMed ID: 9125754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 expression in alopecia areata and androgenetic alopecia.
    Sawaya ME; Bakshandeh H; Hordinsky MK; Penneys NS
    J Cutan Pathol; 1994 Jun; 21(3):229-32. PubMed ID: 7525670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocytes: a possible autoimmune target in alopecia areata.
    Trautman S; Thompson M; Roberts J; Thompson CT
    J Am Acad Dermatol; 2009 Sep; 61(3):529-30. PubMed ID: 19700020
    [No Abstract]   [Full Text] [Related]  

  • 15. No cell-surface-reactive antibodies against cultured autologous melanocytes found in alopecia areata sera.
    Khoury EL; Price VH
    J Invest Dermatol; 1995 May; 104(5 Suppl):24S-25S. PubMed ID: 7738380
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of Th1/Th2 balance in peripheral blood mononuclear cells of patients with alopecia areata.
    Sadeghi S; Sanati MH; Taghizadeh M; Mansouri P; Jadali Z
    Acta Microbiol Immunol Hung; 2015 Sep; 62(3):275-85. PubMed ID: 26551570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptors in androgenic alopecia versus alopecia areata.
    Wallace ML; Smoller BR
    Am J Dermatopathol; 1998 Apr; 20(2):160-3. PubMed ID: 9557785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies in patients with alopecia areata.
    Herzer P; Czarnetzki BM; Holzmann H; Lemmel EM
    Int Arch Allergy Appl Immunol; 1979; 58(2):212-8. PubMed ID: 311349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata.
    Tobin DJ; Fenton DA; Kendall MD
    J Invest Dermatol; 1990 Jun; 94(6):803-7. PubMed ID: 2355182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood lymphocyte subpopulations and antibody dependent, cell-mediated cytotoxicity (ADCC) in alopecia areata and universalis.
    Gu SQ; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1981; 61(2):125-9. PubMed ID: 6165187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.